MedTrace Logo

The Impact of Opioids in Coronary Heart Disease

NCT02740621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2018-04-11

No results posted yet for this study

Summary

In this study, the risk of opioid medications on coronary heart disease in adults is investigated. Patients with the necessity of a coronary angiography and control patients with a non-cardiac disease of the same hospital are inquired with a standardized questionnaire about demographic and clinical risk factors for heart attack. An impact of opioid medications on coronary heart disease is hypothesised (MIOP).

In addition, all patients with coronary angiography should be consulted twice (after 3 and 6 months) to find out how many of these patients have developed a refractory angina pectoris (TRAPS).

Conditions

Sponsors & Collaborators

  • Mundipharma Research GmbH & Co KG

    collaborator INDUSTRY

  • Ruhr University of Bochum

    lead OTHER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-01-31
Completion
2017-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02740621 on ClinicalTrials.gov